Literature DB >> 30183485

New modalities of allergen immunotherapy.

Manish Ramesh1, Merhunisa Karagic1.   

Abstract

Allergen immunotherapy is a rapidly evolving field. Although subcutaneous immunotherapy has been practiced for over a hundred years, improved understanding of the underlying immunological mechanisms has led to the development of new, efficacious and better tolerated allergen-derivatives, adjuvants and encapsulated allergens. Diverse routes of allergen immunotherapy - oral, sublingual, epicutanoeus and intralymphatic - are enabling immunotherapy for anaphylactic food allergies and pollen-food allergy syndrome, while improving the tolerability and effectiveness of aeroallergen immunotherapy. The addition of Anti-IgE therapy decreases adverse effects of subcutaneous and oral immunotherapy.

Entities:  

Keywords:  Allergen Immunotherapy; Anti-IgE; Epicutaneous Immunotherapy; Oral Immunotherapy; Subcutaneous Immunotherapy; Sublingual Immunotherapy; adjuvants

Year:  2018        PMID: 30183485      PMCID: PMC6343630          DOI: 10.1080/21645515.2018.1502126

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  123 in total

Review 1.  Updating the role played by immunotherapy for allergic rhinitis: meta-analysis.

Authors:  Cemal Cingi; Nuray Bayar Muluk; Deniz Hanci; Seckin Ulusoy; Fezan Sahin
Journal:  Int Forum Allergy Rhinol       Date:  2014-11-25       Impact factor: 3.858

2.  Oral immunotherapy for egg allergy in children.

Authors:  Iride Dello Iacono; Maria C Verga; Salvatore Tripodi
Journal:  N Engl J Med       Date:  2012-10-11       Impact factor: 91.245

3.  TLR2 agonists enhance CD8+Foxp3+ regulatory T cells and suppress Th2 immune responses during allergen immunotherapy.

Authors:  Yi-Giien Tsai; Kuender D Yang; Dau-Ming Niu; Jien-Wen Chien; Ching-Yuang Lin
Journal:  J Immunol       Date:  2010-05-07       Impact factor: 5.422

4.  Effect of tree pollen specific, subcutaneous immunotherapy on the oral allergy syndrome to apple and hazelnut.

Authors:  X Bucher; W J Pichler; C A Dahinden; A Helbling
Journal:  Allergy       Date:  2004-12       Impact factor: 13.146

5.  A randomized, double-blind, placebo-controlled study of milk oral immunotherapy for cow's milk allergy.

Authors:  Justin M Skripak; Scott D Nash; Hannah Rowley; Nga H Brereton; Susan Oh; Robert G Hamilton; Elizabeth C Matsui; A Wesley Burks; Robert A Wood
Journal:  J Allergy Clin Immunol       Date:  2008-10-25       Impact factor: 10.793

6.  Rush specific oral tolerance induction in school-age children with severe egg allergy: one year follow up.

Authors:  Naoka Itoh; Yasuharu Itagaki; Kazuyuki Kurihara
Journal:  Allergol Int       Date:  2010-11-25       Impact factor: 5.836

7.  Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy.

Authors:  Brian P Vickery; Amy M Scurlock; Michael Kulis; Pamela H Steele; Janet Kamilaris; Jelena P Berglund; Caitlin Burk; Anne Hiegel; Suzanna Carlisle; Lynn Christie; Tamara T Perry; Robbie D Pesek; Saira Sheikh; Yamini Virkud; P Brian Smith; Mohamed H Shamji; Stephen R Durham; Stacie M Jones; A Wesley Burks
Journal:  J Allergy Clin Immunol       Date:  2013-12-19       Impact factor: 10.793

8.  Rapid desensitization induces internalization of antigen-specific IgE on mouse mast cells.

Authors:  Tatsuya Oka; Eon J Rios; Mindy Tsai; Janet Kalesnikoff; Stephen J Galli
Journal:  J Allergy Clin Immunol       Date:  2013-06-26       Impact factor: 10.793

9.  Effect of anti-IgE therapy in patients with peanut allergy.

Authors:  Donald Y M Leung; Hugh A Sampson; John W Yunginger; A Wesley Burks; Lynda C Schneider; Cornelis H Wortel; Frances M Davis; John D Hyun; William R Shanahan
Journal:  N Engl J Med       Date:  2003-03-10       Impact factor: 91.245

10.  A Pilot Study of Intralymphatic Immunotherapy for House Dust Mite, Cat, and Dog Allergies.

Authors:  Sang Pyo Lee; Seung Joon Choi; Eugene Joe; Sang Min Lee; Min Woo Lee; Jung Woo Shim; Yu Jin Kim; Sun Young Kyung; Jeong Woong Park; Sung Hwan Jeong; Joo Hyun Jung
Journal:  Allergy Asthma Immunol Res       Date:  2017-05       Impact factor: 5.764

View more
  2 in total

Review 1.  Current and Future Strategies for the Diagnosis and Treatment of the Alpha-Gal Syndrome (AGS).

Authors:  Rita Vaz-Rodrigues; Lorena Mazuecos; José de la Fuente
Journal:  J Asthma Allergy       Date:  2022-07-18

Review 2.  The Role of Regulatory T Cells in Epicutaneous Immunotherapy for Food Allergy.

Authors:  Guirong Liu; Manman Liu; Junjuan Wang; Yao Mou; Huilian Che
Journal:  Front Immunol       Date:  2021-07-08       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.